Importantly, however, the study by Dong et al. included GCB-DLBCL patients, the survival difference between patients with or without A20 mutation could theoretically be related to the differences between ABC and GCB, since most patients with A20 mutation was in ABC-DLBCL subgroup. Here, TNFAIP3 is linked to diffuse large B-cell lymphoma.